# EDGAR Filing Document

**Accession Number:** 0002099104
**File Stem:** 0002099104-26-000001
**Filing Date:** 2026-3
**Character Count:** 8846
**Document Hash:** 1f40df58522de5423aec52c273fcd97e
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0002099104-26-000001.hdr.sgml**: 20260317

**ACCESSION NUMBER**: 0002099104-26-000001

**CONFORMED SUBMISSION TYPE**: 3

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20260317

**FILED AS OF DATE**: 20260317

**DATE AS OF CHANGE**: 20260317

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Neglen Niclas
- **CENTRAL INDEX KEY:** 0002099104

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** 3
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-42832
- **FILM NUMBER:** 26759891

**MAIL ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** 10 YORK ROAD
- **CITY:** LONDON
- **PROVINCE COUNTRY:** X0
- **ZIP:** SE1 7ND
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Klarna Group plc
- **CENTRAL INDEX KEY:** 0002003292
- **STANDARD INDUSTRIAL CLASSIFICATION:** FINANCE SERVICES [6199]
- **ORGANIZATION NAME:** 02 Finance
- **EIN:** 000000000
- **STATE OF INCORPORATION:** X0
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **STREET 1:** 10 YORK ROAD
- **CITY:** LONDON
- **STATE:** X0
- **ZIP:** SE1 7ND
- **BUSINESS PHONE:** 0046734205795

**MAIL ADDRESS:**
- **STREET 1:** 10 YORK ROAD
- **CITY:** LONDON
- **STATE:** X0
- **ZIP:** SE1 7ND

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Klarna UK II plc
- **DATE OF NAME CHANGE:** 20231205

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 3

### INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Neglen Niclas<br><sub>(Last) (First) (Middle)</sub><br>10 YORK ROAD<br><sub>(Street)</sub><br>LONDON, X0 SE1 7ND<br><sub>(City) (State) (Zip)</sub> | **3. Issuer Name and Ticker or Trading Symbol**<br>Klarna Group plc [ KLAR ] | **5. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  |
| **2. Date of Event Requiring Statement (Month/Day/Year)**<br>2026-03-17 | **4. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[X] Director   [ ] 10% Owner<br>[X] Officer (give title below)   [ ] Other (specify below)<br>_Chief Financial Officer_ | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities Beneficially Owned

---

|  |  |  |  |
| --- | --- | --- | --- |
| 1. Title of Security | 2. Amount of Securities Beneficially Owned | 3. Ownership Form | 4. Nature of Indirect Beneficial Ownership |
| Klarna Group plc Ordinary Shares | 45615<sup>(1)</sup> | D |  |

---

## Table II - Derivative Securities Beneficially Owned

---

|  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Underlying Securities | 3. Title and Amount of Underlying Securities | 4. Conversion or Exercise Price | 5. Ownership Form | 6. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 4. Conversion or Exercise Price | 5. Ownership Form | 6. Nature of Indirect Beneficial Ownership |
| Larkan AB Restricted Stock Units | <sup>(2)</sup> | <sup>(2)</sup> | Klarna Group plc Ordinary Shares | <sup>(2)</sup> | <sup>(2)</sup> | D |  |
| Larkan SPV Warrants L4:1 | 2027-09-01 | 2027-11-15 | Klarna Group plc Ordinary Shares | 906636<sup>(3)</sup> | 6885.33<sup>(10)</sup> | D |  |
| Larkan SPV Warrants L4:2 | 2027-09-01 | 2027-11-15 | Klarna Group plc Ordinary Shares | 23688<sup>(4)</sup> | 2295.11<sup>(10)</sup> | D |  |
| Larkan SPV Warrant L5:1 | 2027-09-01 | 2027-11-15 | Klarna Group plc Ordinary Shares | 23544<sup>(5)</sup> | 2295.11<sup>(10)</sup> | D |  |
| Larkan SPV Warrant L5:2 | 2027-09-01 | 2027-11-15 | Klarna Group plc Ordinary Shares | 933612<sup>(6)</sup> | 6885.33<sup>(10)</sup> | D |  |
| Larkan SPV Warrant L11:3 | 2028-09-01 | 2028-11-30 | Klarna Group plc Ordinary Shares | 340896<sup>(7)</sup> | 2295.11<sup>(10)</sup> | D |  |
| Larkan SPV Warrants L11:3 | 2028-09-01 | 2028-11-30 | Klarna Group plc Ordinary Shares | 650400<sup>(8)</sup> | 2295.11<sup>(10)</sup> | D |  |
| Klarna Group plc Options | 2026-03-05 | 2029-09-05 | Klarna Group plc Ordinary Shares | 423504<sup>(9)</sup> | 748.5<sup>(10)</sup> | D |  |
| Klarna Group plc Options | 2026-03-05 | 2029-09-05 | Klarna Group plc Ordinary Shares | 941460<sup>(9)</sup> | 1122.75<sup>(10)</sup> | D |  |

---

### Footnotes:

(1) In addition to the ordinary shares reported in this Form 3, the reporting person beneficially owns a number of the Klarna Group plcs (the Issuer) Class B shares.  Each Class B share is entitled to 10 votes per share. Class B shares are not transferable and are not exchangeable for or convertible into ordinary shares.

(2) Represents 14,569 restricted stock units in Larkan AB (Larkan), an indirect subsidiary of Klarna Group plc (the Issuer). Once shares of Larkan are delivered in settlement of the restricted stock units, approximately four shares of Larkan are convertible into one Klarna Group plc ordinary share (Shares). Restricted Stock Units in Larkan vest quarterly, at a total vesting of 25% of the initial grant per year.

(3) Represents warrants to acquire 75,553 shares of Larkan IV AB, a direct subsidiary of the Issuer. Each underlying share of Larkan IV AB is convertible into approximately twelve Shares based on a formula set forth in the applicable award agreement, resulting in 906,636 Shares being subject to the warrant, that is vesting annually by 20% for a period of four years with an additional 20% vesting on August 27, 2027.

(4) Represents warrants to acquire 1,974 shares of Larkan IV AB, a direct subsidiary of the Issuer. Each underlying share of Larkan IV AB is convertible into approximately twelve Shares based on a formula set forth in the applicable award agreement, resulting in 23,688 Shares being subject to the warrant, that is vesting annually by 20% for a period of four years with an additional 20% vesting on August 27, 2027.

(5) Represents warrants to acquire 1,962 shares of Larkan V AB, a direct subsidiary of the Issuer. Each underlying share of Larkan V AB is convertible into approximately twelve Shares based on a formula set forth in the applicable award agreement, resulting in 23,544 Shares being subject to the warrant, that is vesting annually by 20% for a period of four years with an additional 20% vesting on August 27, 2027.

(6) Represents warrants to acquire 77,801 shares of Larkan V AB, a direct subsidiary of the Issuer. Each underlying share of Larkan V AB is convertible into approximately twelve Shares based on a formula set forth in the applicable award agreement, resulting in 933,612 Shares being subject to the warrant, that is vesting annually by 20% for a period of four years with an additional 20% vesting on August 27, 2027.

(7) Represents warrants to acquire 28,408 shares of Larkan XI AB, a direct subsidiary of the Issuer. Each underlying share of Larkan XI AB is convertible into approximately twelve Shares based on a formula set forth in the applicable award agreement, resulting in 340,896 Shares being subject to the warrant, that is vesting annually over four years in equal instalments.

(8) Represents warrants to acquire 54,200 shares of Larkan XI AB, a direct subsidiary of the Issuer. Each underlying share of Larkan XI AB is convertible into approximately twelve Shares based on a formula set forth in the applicable award agreement, resulting in 650,400 Shares being subject to the warrant, that is vesting annually over four years in equal instalments.

(9) Represents an option to acquire Shares that vest in four equal annual installments beginning on the first anniversary of the grant date.

(10) This is in SEK.

**Signature:** Boudien Moerman, as attorney-in-fact  
**Date:** 2026-03-17

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**